In a recent study, short-term pharmacological inhibition of ADAM17 via delivery of recombinant prodomain (PD) impairs TNF-induced necroptosis in tumor endothelial cells and subsequently blocks metastasis [306]. The gene discussed is TNF; the disease is neoplasm.